Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution

Gallin JI, Snyderman R, Fearon DT, Haynes BF, Nathan C, editors. Inflammation: basic principles and clinical correlates. Philadelphia: Lippincott Williams & Wilkins, 1999.

Samuelsson, 1987, Leukotrienes and lipoxins: structures biosynthesis and biological effects, Science, 237, 1171, 10.1126/science.2820055

Cronstein, 1999, Sites of action for future therapy: an adenosine-dependent mechanism by which aspirin retains its antiinflammatory activity in cyclooxygenase-2 and NFkB knockout mice, Osteoarthritis Cartilage, 7, 361, 10.1053/joca.1998.0236

Cronstein, 1999, Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFκB, Proc. Natl. Acad. Sci. USA, 96, 6377, 10.1073/pnas.96.11.6377

Krump, 1997, Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils, J. Exp. Med., 186, 1401, 10.1084/jem.186.8.1401

Qiu, 2000, IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment, Proc. Natl. Acad. Sci. USA, 97, 4267, 10.1073/pnas.97.8.4267

Serhan, 1994, Lipoxin biosynthesis and its impact in inflammatory and vascular events, Biochim. Biophys. Acta, 1212, 1, 10.1016/0005-2760(94)90185-6

Serhan, 1996, Lipid mediator networks in cell signaling: update and impact of cytokines, FASEB J., 10, 1147, 10.1096/fasebj.10.10.8751717

de Waal Malefyt R. Inflammation: basic principles and clinical correlates. In: Gallin JI, Snyderman R, Fearon DT, Haynes BF, Nathan C, editors. Philadelphia: Lippincott Williams & Wilkins, 1999. p. 837.

Diamond, 1999, Regulation of leukocyte trafficking by lipoxins, Clin. Chem. Lab. Med., 37, 293, 10.1515/CCLM.1999.051

Marcus, 1995, Aspirin as prophylaxis against colorectal cancer, N. Engl. J. Med., 333, 656, 10.1056/NEJM199509073331011

Vane JR. Les Prix Nobel: Nobel prizes, presentations, biographies and lectures. Stockholm: Almqvist & Wiksell, 1982. p. 181.

Chiang, 1998, Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA, J. Pharmacol. Exp. Ther., 287, 779

Clària, 1995, Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell–leukocyte interactions, Proc. Natl. Acad. Sci. USA, 92, 9475, 10.1073/pnas.92.21.9475

Clària, 1996, Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation, Mol. Med., 2, 583, 10.1007/BF03401642

Fierro, 2001, A novel inhibitor of angiogenesis: aspirin-triggered 15R lipoxin A4, FASEB J., 15, A949

Showell HJ, Cooper K. Inflammation: basic principles and clinical correlates. In: Gallin JI, Snyderman R, editors. Philadelphia: Lippincott Williams & Wilkins, 1999. p. 1177.

Malaviya, 2000, Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis, J. Leukoc. Biol., 67, 841, 10.1002/jlb.67.6.841

Swan, 2000, Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet: a randomized controlled trial, Ann. Intern. Med., 133, 1, 10.7326/0003-4819-133-1-200007040-00002

Cannon, 2000, Arthritis Rheum., 43, 978, 10.1002/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO;2-0

Serhan, 1995, Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils, Biochemistry, 34, 14609, 10.1021/bi00044a041

Serhan, 1997, Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell–cell interactions or a therapeutic opportunity?, Prostaglandins, 53, 107, 10.1016/S0090-6980(97)00001-4

Levy, 2001, Lipid mediator class switching during acute inflammation: signals in resolution, Nat. Immunol., 2, 612, 10.1038/89759

Qiu FH, Devchand PR, Wada K, Serhan CN. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils. FASEB J October 29, 2001, 10. 1096/fj. 01-0576fje (available at www.fasebj.org).

Varani, 1994, Mechanism of neutrophil-dependent and neutrophil-independent endothelial cell injury, Biol. Signals, 3, 1, 10.1159/000109521

Serhan, 1990, Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro, J. Clin. Invest., 85, 772, 10.1172/JCI114503

Edenius, 1991, On the mechanism of transcellular lipoxin formation in human platelets and granulocytes, Eur. J. Biochem., 199, 401, 10.1111/j.1432-1033.1991.tb16137.x

Lehr, 1994, Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo, Proc. Natl. Acad. Sci. USA, 91, 7688, 10.1073/pnas.91.16.7688

Brady, 1992, Adhesion promotes transcellular leukotriene biosynthesis during neutrophil–glomerular endothelial cell interactions: inhibition by antibodies against CD18 and l-selectin, Biochem. Biophys. Res. Commun., 186, 1307, 10.1016/S0006-291X(05)81548-7

Herschman, 1998, Recent progress in the cellular and molecular biology of prostaglandin synthesis, Trends Cardiovasc. Med., 8, 145, 10.1016/S1050-1738(98)00004-8

Samuelsson, B. Les Prix Nobel: Nobel prizes, presentations, biographies and lectures. Stockholm: Almqvist & Wiksell, 1982. p. 153.

Serhan, 2000, The scent of a phagocyte: advances on leukotriene B4 receptors, J. Exp. Med., 192, F5, 10.1084/jem.192.3.F5

Fiore, 1989, Phospholipid bilayers enhance the stability of leukotriene A4 and epoxytetraenes: stabilization of eicosanoids by liposomes, Biochem. Biophys. Res. Commun., 159, 477, 10.1016/0006-291X(89)90017-X

Nassar, 1994, Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes, J. Biol. Chem., 269, 27631, 10.1016/S0021-9258(18)47031-7

Levy, 1993, Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins, J. Clin. Invest., 92, 1572, 10.1172/JCI116738

Levy, 1997, Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer, FASEB J., 11, 234, 10.1096/fasebj.11.4.9068612

Savage, 1995, Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty, Circulation, 92, 3194, 10.1161/01.CIR.92.11.3194

Sneader, 2000, The discovery of aspirin: a reappraisal, BMJ, 321, 1591, 10.1136/bmj.321.7276.1591

Lee, 1989, Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-l-methionyl-l-leucyl-l-phenylalanine, Clin. Sci., 77, 195, 10.1042/cs0770195

Papayianni, 1996, Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells, J. Immunol., 156, 2264, 10.4049/jimmunol.156.6.2264

Hachicha, 1999, Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1α-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis, J. Exp. Med., 189, 1923, 10.1084/jem.189.12.1923

Colgan, 1993, Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers, J. Clin. Invest., 92, 75, 10.1172/JCI116601

Takano, 1997, Aspirin-triggered 15-epi-lipoxin A4 and LXA4 stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors, J. Exp. Med., 185, 1693, 10.1084/jem.185.9.1693

Takano, 1998, Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues, J. Clin. Invest., 101, 819, 10.1172/JCI1578

Clish, 1999, Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo, Proc. Natl. Acad. Sci. USA, 96, 8247, 10.1073/pnas.96.14.8247

Bandeira-Melo, 2000, Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia, J. Immunol., 164, 1029, 10.4049/jimmunol.164.2.1029

Chiang, 1999, Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion, J. Clin. Invest., 104, 309, 10.1172/JCI7016

Gewirtz, 1998, Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs, J. Clin. Invest., 101, 1860, 10.1172/JCI1339

Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, Serhan CN. Selectivity of recombinant human leukotriene D4 leukotriene B4 and lipoxin A4 receptors with aspirin-triggered 15-epi-LXA4 and regulation of vascular and inflammatory responses. Am J Pathol 2001;158:3.

Tamaoki, 1995, Lipoxin A4 inhibits cholinergic neurotransmission through nitric oxide generation in the rabbit trachea, Eur. J. Pharmacol., 287, 233, 10.1016/0014-2999(95)00490-4

Serhan, 1984, Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes, Proc. Natl. Acad. Sci. USA, 81, 5335, 10.1073/pnas.81.17.5335

Ford-Hutchinson, 1991, Arachidonate 15-lipoxygenase characteristics and potential biological significance, Eicosanoids, 4, 65

Sigal, 1994, Human 15-lipoxygenase: a potential effector molecule for interleukin-4, Adv. Prostaglandin Thromboxane Leukot. Res., 22, 309

Katoh, 1994, Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNA in rat nephrotoxic nephritis, Kidney Int., 46, 341, 10.1038/ki.1994.280

Anderson, 1994, TH2 and TH2-like cells in allergy and asthma: pharmacological perspectives, Trends Pharmacol. Sci., 15, 324, 10.1016/0165-6147(94)90027-2

Pouliot, 1994, Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils, J. Exp. Med., 179, 1225, 10.1084/jem.179.4.1225

Ring, 1996, Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte-macrophage colony stimulating factor and interleukin-3, J. Clin. Invest., 97, 1293, 10.1172/JCI118545

L’Heureux, 1995, Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GROAa, stimulates phospholipase D activity, Blood, 85, 522, 10.1182/blood.V85.2.522.522

Lefer, 1988, Lipoxins A4 and B4: comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity, Proc. Natl. Acad. Sci. USA, 85, 8340, 10.1073/pnas.85.21.8340

Dahlén SE, Serhan CN. Lipoxygenases and their products. In: Wong A, Crooke ST, editors. San Diego: Academic Press, 1991. p. 235.

Lee, 1991, Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships, Biochem. Biophys. Res. Commun., 180, 1416, 10.1016/S0006-291X(05)81354-3

Badr, 1989, Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor, Proc. Natl. Acad. Sci. USA, 86, 3438, 10.1073/pnas.86.9.3438

Fiore, 1990, Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils, J. Exp. Med., 172, 1451, 10.1084/jem.172.5.1451

Chavis, 1995, 5,15-diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers, Biochem. Biophys. Res. Commun., 207, 273, 10.1006/bbrc.1995.1183

Chavis, 1996, 15(S)-Dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors, J. Exp. Med., 183, 1633, 10.1084/jem.183.4.1633

Thomas, 1995, Conversion of endogenous arachidonic acid to 5,15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis, Inflamm. Res., 44, 121, 10.1007/BF01782022

Shen, 1996, Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development, J. Clin. Invest., 98, 2201, 10.1172/JCI119029

Brezinski, 1990, Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids, Proc. Natl. Acad. Sci. USA, 87, 6248, 10.1073/pnas.87.16.6248

Edenius, 1988, Transcellular conversion of endogenous arachidonic acid to lipoxins in mixed human platelet-granulocyte suspensions [published erratum appears in Biochem Biophys Res Commun 28;159(1):370], Biochem. Biophys. Res. Commun., 157, 801, 10.1016/S0006-291X(88)80320-6

Lindgren, 1993, Transcellular biosynthesis of leukotrienes and lipoxins via leukotriene A4 transfer, Trends Pharmacol. Sci., 14, 351, 10.1016/0165-6147(93)90092-X

Corey, 1986, A stereoselective and practical synthesis of 5,6(S,S)-epoxy-15(S)-hydroxy-7(E),9(E),11(Z),13(E)-eicosatetraenoic acid (4), possible precursor of the lipoxins, Tetrahedron Lett., 27, 5173, 10.1016/S0040-4039(00)85161-8

Sheppard, 1992, Lipoxin generation by human megakaryocyte-induced 12-lipoxygenase, Biochim. Biophys. Acta, 1133, 223, 10.1016/0167-4889(92)90073-K

Romano, 1992, Lipoxin generation by permeabilized human platelets, Biochemistry, 31, 8269, 10.1021/bi00150a021

Romano, 1993, Lipoxin synthase activity of human platelet 12-lipoxygenase, Biochem. J., 296, 127, 10.1042/bj2960127

Lehr, 1994, P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo, Lab. Invest., 71, 380

Mayadas, 1996, Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice, Kidney Int., 49, 1342, 10.1038/ki.1996.190

Papayianni, 1995, Transcellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis, Kidney Int., 47, 1295, 10.1038/ki.1995.184

Garrick, 1991, Enzymatic formation and regulatory function of lipoxins and leukotriene B4 in rat kidney mesangial cells, Adv. Exp. Med. Biol., 314, 361, 10.1007/978-1-4684-6024-7_25

Edenius, 1990, Lipoxin formation in human nasal polyps and bronchial tissue, FEBS Lett., 272, 25, 10.1016/0014-5793(90)80440-T

Tornhamre, 1992, Conversion of 5,6-dihydroxyeicosatetraenoic acids. A novel pathway for lipoxin formation by human platelets, FEBS Lett., 304, 78, 10.1016/0014-5793(92)80593-6

Rowley, 1997, Haemostasis in fish – an evolutionary perspective, Thromb. Haemost., 77, 227, 10.1055/s-0038-1655943

Gronert, 1995, Thrombocytes are the predominant source of endogenous sulfidopeptide leukotrienes in the bullfrog (Rana catesbeiana), Biochim. Biophys. Acta, 1255, 311, 10.1016/0005-2760(94)00248-W

Maddox, 1997, Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein linked lipoxin A4 receptor, J. Biol. Chem., 272, 6972, 10.1074/jbc.272.11.6972

Stenke, 1994, Leukotrienes and lipoxins--new potential performers in the regulation of human myelopoiesis, Leukemia Res., 18, 727, 10.1016/0145-2126(94)90053-1

Lee, 1990, Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases, Am. Rev. Respir. Dis., 141, 1453, 10.1164/ajrccm/141.6.1453

Levy, 1993, Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA, Lipids, 28, 1047, 10.1007/BF02537069

Brezinski, 1992, Angioplasty triggers intracoronary leukotrienes and lipoxin A4 Impact of aspirin therapy, Circulation, 86, 56, 10.1161/01.CIR.86.1.56

Stenke, 1990, Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia, Adv. Prostaglandin Thromboxane Leukot. Res., 21B, 883

Herschman, 1996, Prostaglandin synthase 2, Biochim. Biophys. Acta, 1299, 125, 10.1016/0005-2760(95)00194-8

Xiao, 1997, Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2, Biochemistry, 36, 1836, 10.1021/bi962476u

Hennekens, 1994, The benefits of aspirin in acute myocardial infarction. Still a well-kept secret in the United States, Arch. Intern. Med., 154, 37, 10.1001/archinte.1994.00420010055007

Giovannucci, 1995, Aspirin and the risk of colorectal cancer in women, N. Engl. J. Med., 333, 609, 10.1056/NEJM199509073331001

Sanak, 2000, Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics, Eur. Respir. J., 16, 44, 10.1034/j.1399-3003.2000.16a08.x

Clària, 1998, Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites, Gastroenterology, 115, 147, 10.1016/S0016-5085(98)70376-2

Stenke, 1991, Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia, Blood, 78, 2989, 10.1182/blood.V78.11.2989.2989

Stenke, 1991, Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia, Adv. Prostaglandin Thromboxane Leukot. Res., 21B, 883

Stenke, 1991, Formation and proliferative effects of lipoxins in human bone marrow, Biochem. Biophys. Res. Commun., 180, 255, 10.1016/S0006-291X(05)81285-9

Pouliot, 2000, Lipoxin A4 analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease, Biochemistry, 39, 4761, 10.1021/bi992551b

Maddox, 1998, Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity, FASEB J., 12, 487, 10.1096/fasebj.12.6.487

Chiang, 2000, Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation, J. Exp. Med., 191, 1197, 10.1084/jem.191.7.1197

Gewirtz, 1999, LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation, Am. J. Physiol., 276, C988, 10.1152/ajpcell.1999.276.4.C988

Filep, 1999, Anti-inflammatory actions of lipoxin A4 stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil–endothelial interactions, Blood, 94, 4132, 10.1182/blood.V94.12.4132

Gronert, 1998, Identification of a human enterocyte lipoxin A4 receptor that is regulated by IL-13 and IFN-γ and inhibits TNF-α-induced IL-8 release, J. Exp. Med., 187, 1285, 10.1084/jem.187.8.1285

Dahlén B. Leukotrienes as mediators of asthma induced by aspirin and allergen (thesis). Stockholm: Department of Thoracic Medicine, Karolinska Institutet, 1993. p. 68.

Node, 1999, Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids, Science, 285, 1276, 10.1126/science.285.5431.1276

Sodin-Semrl, 2000, Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases, J. Immunol., 164, 2660, 10.4049/jimmunol.164.5.2660

Godson, 2000, Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages, J. Immunol., 164, 1663, 10.4049/jimmunol.164.4.1663

Shinmura, 2000, Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits, Proc. Natl. Acad. Sci. USA, 97, 10197, 10.1073/pnas.97.18.10197

Fiore, 1994, Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor, J. Exp. Med., 180, 253, 10.1084/jem.180.1.253

Gronert, 2001, Selectivity of recombinant human leukotriene D4 leukotriene B4 and lipoxin A4 receptors with aspirin-triggered 15-epi-LXA4 and regulation of vascular and inflammatory responses, Am. J. Pathol., 158, 3, 10.1016/S0002-9440(10)63937-5

Kang, 2000, Mutations of serine 235–237 and tyrosine 302 residues in the human lipoxin A4 receptor intracellular domains result in sustained signaling, Biochemistry, 39, 13551, 10.1021/bi001196i

Godson, 2000, Lipoxins: novel anti-inflammatory therapeutics?, Curr. Opin. Invest. Drugs, 1, 380

Serhan, 2001, Nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4, J. Immunol., 166, 3650, 10.4049/jimmunol.166.6.3650

McMahon, 2001, Lipoxins: revelations on resolution, Trends. Pharmacol. Sci., 22, 391, 10.1016/S0165-6147(00)01771-5

Serhan, 2001, Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side, Arch. Immunol. Ther. Exp., 49, 177